Thermo Fisher Scientific and PRECISE Partner on Singapore Proteomics Study
The collaboration will use multi-omic platforms and AI-driven analytics to identify disease patterns and improve patient stratification within the PRECISE-SG100K study.
The collaboration will use multi-omic platforms and AI-driven analytics to identify disease patterns and improve patient stratification within the PRECISE-SG100K study.
Co-Diagnostics and Arabian Eagle Manufacturing have secured land in Sudair Industrial City, Saudi Arabia, to build a facility for manufacturing molecular diagnostic instruments and assays, supporting regional expansion in the Middle East and North Africa.
The new leader brings over 30 years of industry experience from Bayer, Siemens, and Ortho Clinical Diagnostics to lead commercial expansion.
The deal adds a solid-phase cytometry platform that delivers sterility test results in four days versus a traditional 14-day incubation period.
Read MoreThe recipient is recognized for contributions to molecular diagnostics and women’s health screening technologies.
Read MoreThe laboratory services company updates full-year guidance following continued momentum in diagnostics and central laboratory businesses.
Read MoreThe 18,000-sq-ft facility will support the expansion of immunogenicity testing and target binding technologies.
Read MoreTeams complete whole human genome sequencing and analysis in under four hours, demonstrating potential for same-day NICU workflows.
Read MoreThe new interim CEO currently serves as senior vice president and chief operating officer at the organization.
Read MoreThe extended agreement through 2032 broadens commercial rights beyond the recently launched carrier screening kit to accelerate diagnostic innovation.
Read MoreThe joint consensus recommendation from AMP, ASCO, and CAP addresses variability in molecular profiling report formats across laboratories.
Read MoreThe proteomics company will use capital to advance partner-driven product development and commercial operations from new California headquarters.
Read MoreThe new Louisville campus aims to deliver next-morning molecular diagnostic results to 5 million patient samples annually nationwide.
Read MoreThe Alzheimer’s diagnostics company will relocate headquarters and expand CLIA-certified lab operations to the Cortex Innovation District by late 2026.
Read MoreThe deal includes customer accounts and operating assets focused on cancer-related clinical testing services across the United States.
Read MoreThe College of American Pathologists will begin searching for a permanent replacement while naming an interim CEO.
Read MoreThe global diagnostics manufacturer plans to transform its West Virginia sales and distribution site into a manufacturing hub for next-generation diagnostic products.
Read MoreThe diagnostics company will participate in a fireside chat on Sept 10, focusing on its in vitro diagnostic technologies.
Read More